carbamazepine has been researched along with Dystonic Disorders in 5 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Dystonic Disorders: Acquired and inherited conditions that feature DYSTONIA as a primary manifestation of disease. These disorders are generally divided into generalized dystonias (e.g., dystonia musculorum deformans) and focal dystonias (e.g., writer's cramp). They are also classified by patterns of inheritance and by age of onset.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carbamazepine therapy was initiated with dramatic response." | 1.62 | Favorable response to carbamazepine therapy in genetically proven myoclonus-dystonia child. ( Alghamdi, A; Alghamdi, H; Aljabri, MF; Alomairi, N; Kamal, NM, 2021) |
| "Adult-onset focal dystonia in the upper limbs is well characterized whereas such dystonia has been rarely reported in the lower limbs, especially in proximal parts." | 1.33 | Runner's dystonia. ( Jankovic, J; Wu, LJ, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aljabri, MF | 1 |
| Kamal, NM | 1 |
| Alghamdi, A | 1 |
| Alghamdi, H | 1 |
| Alomairi, N | 1 |
| Sanjari Moghaddam, H | 1 |
| Tafakhori, A | 1 |
| Darvish, H | 1 |
| Mahmoudi-Gharaei, J | 1 |
| Jamali, F | 1 |
| Aghamollaii, V | 1 |
| Borchert, A | 1 |
| Möddel, G | 1 |
| Schilling, M | 1 |
| Yamamoto, T | 1 |
| Takiguchi, N | 1 |
| Tamura, N | 1 |
| Iwasaki, S | 1 |
| Araki, N | 1 |
| Wu, LJ | 1 |
| Jankovic, J | 1 |
5 other studies available for carbamazepine and Dystonic Disorders
| Article | Year |
|---|---|
Favorable response to carbamazepine therapy in genetically proven myoclonus-dystonia child.
Topics: Anticonvulsants; Carbamazepine; DNA; DNA Mutational Analysis; Dystonic Disorders; Genetic Testing; H | 2021 |
Treatment of Myoclonus-dystonia with carbamazepine.
Topics: Anticonvulsants; Carbamazepine; Child; Dystonic Disorders; Female; Humans | 2018 |
Teaching Video NeuroImages: paroxysmal kinesigenic dyskinesia.
Topics: Anticonvulsants; Brain; Carbamazepine; Chorea; Dystonic Disorders; Electroencephalography; Humans; M | 2009 |
An unusual focal leg dystonia in descending stairs responsive to anticonvulsants.
Topics: Adult; Anticonvulsants; Basal Ganglia; Brain; Carbamazepine; Cerebrovascular Circulation; Dyskinesia | 2012 |
Runner's dystonia.
Topics: Adult; Anti-Dyskinesia Agents; Anticonvulsants; Botulinum Toxins; Carbamazepine; Dyskinesias; Dyston | 2006 |